Editorial Board

116 Editors in 16 Countries/Region

Italy (37)
China (31)
USA (14)
Germany (7)
Singapore (5)
Japan (4)
Greece (4)
South Korea (3)
Spain (2)
France (2)
United Kingdom (2)
Switzerland (1)
Finland (1)
Belgium (1)
Australia (1)
Turkey (1)

Editor-in-Chief

Guangwen Cao

gcao@smmu.edu.cn

Chairman, Professor, and PhD Supervisor at Department of Epidemiology, Second Military Medical University, Shanghai, China.

Research Interests: hepatitis B virus, hepatocellular carcinoma, evolution, prediction, prophylaxis, therapeutic option, predicative biomarker, prognostic biomarkers

Contributions:

Association of human leukocyte antigen-DR-DQ-DP haplotypes with the risk of hepatitis B virus-related hepatocellular carcinoma

Executive Chief Editor

Giuliano Ramadori

Professor of Medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.

Research Interests: gene expression, liver cells (hepatocytes, kupffer cells, endothelial cells, stellate cells), pathogenesis, inflammation, cancer development, animal models of liver cancer diagnostic procedures and therapy, COVID-19 diagnostic and treatment, mechanisms of acute-phaseresponse, gastrointestinal cancer diagnostic and endoscopic therapy, systemic cancer therapy, tumor microenviroment analysis, liver diseases diagnostic, therapy, iron metabolism, radiation biology

Honorary Editors-in-Chief

Masao Omata

Department of Gastroenterology, University of Tokyo, Tokyo, Japan.

Research Interests: hepatology, gastroenterology, oncology

Shu-Kui Qin

Clinical Oncology Department, Nanjing Jinling Hospital, Nanjing, Jiangsu, China.

Research Interests: gastrointestinal cancers, treatment, liver cancer, primary liver cancer

Associate Chief Editors

Patrizia Burra

Gastroenterology Unit and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, University Hospital of Padua, Italy.

Research Interests: liver transplantation (HBV prophylaxis after transplantation, liver transplantation for MAFLD and MASH, frailty and obesity, early liver transplantation for acute alcoholic hepatitis), hepatocellular carcinoma, primary sclerosing cholangitis, cholangiocarcinoma

Contributions:

The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

Hepatic venous pressure gradient in hepatic resection for hepatocellular carcinoma

Francesco De Cobelli

Department of Radiology, IRCCS San Raffaele Hospital, Milan, Italy.

Research Interests: characterization of oncological imaging, interventional oncology, heptobiliary locoregional treatments, hepatocellular carcinoma, cholangiocarcinoma

Contributions:

Radiological imaging and non-surgical local treatments for cholangiocarcinoma

Surgery for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: milestone changes in the last two decades potentially affecting current guidelines

Jia Fan

Department of Liver Surgery, Fudan University, Shanghai, China.

Research Interests: hepatocellular carcinoma, clinical diagnosis, treatment and basic research of liver cancer

Contributions:

Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon

Comprehending the therapeutic effects of stereotactic body radiation therapy for small hepatocellular carcinomas based on imagings

Fabio Farinati

Department of Surgical and Gastroenterological Sciences, Padua University, Padua, Italy.

Research Interests: hepatocellular carcinoma, precision medicine, non-alcoholic steatohepatitis, microRNA, locoregional treatments

Guido Gerken

Department of Gastroenterology and Hepatology, University of Essen, Essen, Germany.

Research Interests: internal medicine, gastroenterology, hepatology, clinical virology, clinical immunology, endoscopy, liver transplantation, autoimmunity, infectiology, visceral medicine, acute and terminal liver failure, molecular pathomechanisms of liver failure, fibrosis progression of chronic liver diseases, evaluation of mini-laparoscopy for the diagnosis of chronic liver diseases, crohn’s disease, ulcerative colitis, autoimmune hepatitis, viral hepatitis and HIV coinfection, hepatocellular carcinoma, establishment of biomarkers in gastroenterology

Contributions:

Evaluation of liver function before and during therapy

Salvatore Gruttadauria

Department of Surgery, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS-ISMETT), Palermo, Italy.

Research Interests: liver resection, liver transplantation, laparoscopic surgery, laparoscopic thermal ablation, living related liver transplantation, living donor

Contributions:

Protective benefit of minimally invasive liver surgery for hepatocellular carcinoma prior to transplant

Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS)

Systemic treatment for hepatocellular carcinoma beyond milan criteria on the waitlist: is it time for a neoadjuvant therapy?

Nuh Rahbari

Department of General and Visceral Surgery, Ulm University Hospital, Ulm, Germany.

Research Interests: hepatectomy, minimally invasive surgery, hepatocellular carcinoma, immunotherapy

Feng Shen

Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.

Research Interests: intrahepatic cholangiocarcinoma, treatment of hepatobiliary and pancreatic diseases

Claudio Tiribelli

Fondazione Italiana Fegato – Italian Liver Foundation NPO, AREA Science Park, Trieste, Italy.

Research Interests: bilirubin, neonatal jaundice, metabolic liver diseases, hepatocellular carcinoma, stem cells in hepatocellular carcinoma, crigler-najjar syndrome, translational medicine

Contributions:

Novel high-throughput applications for NAFLD diagnostics and biomarker discovery

The Fatty liver Index (FLI) 15 years later: a reappraisal

Georgios Tsoulfas

Surgery, Aristoteleion University of Thessaloniki, Thessaloniki, Greece.

Research Interests: hepatobiliary surgery, primary and secondary hepatic malignancies, ischemia/reperfusion injury, solid organ transplantation, medical/surgical education, 3D printing

Contributions:

Frailty and Liver resection: where do we stand?

The evolution of minimally invasive surgery in liver transplantation for hepatocellular carcinoma

Liver transplantation for hepatoblastoma

Sudhakar K. Venkatesh

Abdominal Imaging Division, Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Research Interests: liver fibrosis, chronic liver disease, autoimmune liver diseases, hepatocellular carcinoma, cholangiocarcinoma

Contributions:

CT of hepatocellular carcinoma in non-alcoholic fatty liver disease: imaging characteristics and inter-rater agreement

Kai-Chun Wu

Emergency Room of Digestive Diseases, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xi'an, Shaanxi, China.

Research Interests: gastrointestinal cancers, treatment, liver cancer, gut

Editorial Board Members

Luca Aldrighetti

Hepatobiliary and General Surgery Division, San Raffaele Hospital, Milan, Italy.

Research Interests: surgical treatment of hepatobiliary diseases, minimally invasive surgery, resection, cholangiocarcinoma

Contributions:

Surgery for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: milestone changes in the last two decades potentially affecting current guidelines

Anna Alisi

Research Unit of Molecular Genetics of Complex Phenotypes, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Research Interests: non-alcoholic fatty liver disease, cirrhosis

Francesco Ardito

Hepatobiliary Surgery Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.

Research Interests: minimally invasive liver surgery, liver resection for malignant and benign hepatobiliary disease, hepatocellular carcinoma, cholangiocarcinoma, liver metastases

Matias A Avila

Hepatology Program, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

Research Interests: molecular mechanisms, carcinogenesis, liver regeneration, liver fibrosis, chronic liver diseases

Clara Balsano

Internal Medicine (MED 09), Department of Life, Health and Environmental Sciences (MESVA), University of L'Aquila, L'Aquila, Italy.

Research Interests: new immunological treatments, autoimmune hepatitis, role of hepatitis B virus and hepatitis B virus viral proteins in tissue damage, biomarkers, nonalcoholic fatty liver disease, steatohepatitis, gender differences, response, innovative treatments

Irene Bargellini

Department of Surgical Sciences, University of Turin, Turin, Italy; Diagnostic and Interventional Radiology Department, Candiolo Cancer, Institute, IRCCS, FPO, Candiolo, Italy.

Research Interests: loco-regional treatments of liver tumors, ablation, transaterial chemoembolization, transarterial readioembolization, imaging response criteria

Eliza Wright Beal

Departments of Surgery and Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.

Research Interests: access to surveillance for hepatocellular carcinoma, treatment of hepatocellular carcinoma, hepatitis B virus, hepatitis C virus, cirrhosis, minimally invasive hepatectomy, systemic cancer therapy, intrahepatic cholangiocarcinoma

Stefano Bellentani

Gastroenterology and Hepatology Service, Clinica Santa Chiara, Locarno, Switzerland.

Research Interests: metabolic associated fatty liver disease, non-alcoholic fatty liver disease, endocrine disorders, sex differences, metabolic syndrome, liver, hypobetalipoproteinemia, dysmetabolism in hepatitis C virus

Contributions:

The Fatty liver Index (FLI) 15 years later: a reappraisal

Andrea Belli

Department of Abdominal Oncology, HPB Surgical Oncology, National Cancer Institute - G. Pascale - IRCCS, Naples, Italy.

Research Interests: liver resection, minimally invasive surgery, robotic surgery, hepatocellular carcinoma, cholangiocarcinoma

Contributions:

Robotic surgery of gallbladder cancer

Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS)

Antonio Benedetti

Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, Ancona, Italy.

Research Interests: cholangiocarcinoma, hepatocellular carcinoma, immunotherapy

Contributions:

The role of tumor microenvironment in cholangiocarcinoma

Antonio Bertoletti

Division Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore City, Singapore.

Research Interests: immunopathogenesis, hepatitis C virus infection, SARS-CoV1/2 infections, new immunological based therapies (T cell receptor-redirected T cells), treatment of hepatitis C virus, SARS-CoV-2, hepatocellular carcinoma

Stefano Brillanti

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.

Research Interests: hepatocellular carcinoma, hepatitis B/C virus, cirrhosis, non-alcoholic steatohepatitis

Elisa Callegari

Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.

Research Interests: hepatocellular carcinoma, cirrhosis, transgenic mice, micro RNA, therapy, prophylaxis, liquid biopsies

Isabelle Chemin

INSERM, Hepatology Institute Lyon, Lyon, France.

Research Interests: hepatitis B, hepatitis delta, hepatocellular carcinoma, animal models, aflatoxin B1, variants, occult hepatitis B

Jian-Guo Chen

Qidong Liver Cancer Institute, Tumor Institute, Tumor Hospital, Nantong University, Nantong, Jiangsu, China.

Research Interests: hepatitis B virus, prevention, HBsAg, survival

Xiao-Bing Chen

Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China.

Research Interests: mechanisms of immunotherapy resistance, recurrence and metastasis

Special Issue:

Immune Subtypes and Immunotherapeutic Responses in Malignancies

William C. Cho

Department of Clinical Oncology, Queen Elizabeth Hospital Hong Kong, Hong Kong, China.

Research Interests: cancer biomarkers, genomics, proteomics, non-coding RNA, drug repurposing

Contributions:

Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance

Special Issue:

The Emerging Role of Extracellular Vesicles in Cancer

Kenneth Siu Ho Chok

Department of Surgery, University of Hong Kong, Hongkong, China.

Research Interests: hepatocellular carcinoma, liver transplantation, intrahepatic cholangiocarcinoma

Contributions:

Experience of living donor liver transplantation for hepatocellular carcinoma in the University of Hong Kong Hospital

Evangelos Cholongitas

First Department of Internal Medicine, "Laiko" General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece.

Research Interests: cirrhosis, liver transplantation, NAFLD, hepatocellular carcinoma

Umberto Cillo

Department of Surgery, Oncology and Gastroenterology, Hepatobiliary Surgery and Liver Transplantation Unit, Padova University Hospital, Padova, Italy.

Research Interests: hepatobiliary surgery, liver surgery, liver cancer surgery, gastrointestinal surgical oncology, orthotopic liver transplantation, living donor liver transplantation, pediatric liver transplantation

Contributions:

The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

Valli De Re

Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.

Research Interests: HCV, molecular pathogenesis, biomarkers, hepatocellular carcinoma

Paolo De Simone

Hepatobiliary surgery and liver transplantation, University of Pisa Medical School Hospital, Pisa, Italy.

Research Interests: liver transplant, liver surgery, liver malignancy, hepatocellular carcinoma, donor surgery

Renumathy Dhanasekaran

Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.

Research Interests: liver cancer, HCC, tumor progression, cancer immunology, macrophages

Marcello Di Martino

Department of Hepatobiliary and Liver Transplant Surgery, A.O.R.N. Cardarelli, Naples, Italy.

Research Interests: hepatocellular carcinoma, liver metastasis, liver cirrhosis, liver imaging, liver resection

Contributions:

Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma

Hui-Guo Ding

Department of Gastroenterology and Hepatology, Beijing You An Hospital affiliated to Capital Medical University, Beijing, China.

Research Interests: clinical diagnosis, treatment and research of liver cirrhosis, portal hypertension and its complications, early liver cancer diagnosis and screening, ascites, gastrointestinal bleeding, malnutrition, hepatic encephalopathy, pancreatic biliary disease, endoscopic minimally invasive diagnosis and treatment

Contributions:

Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)

Matteo Donadon

Division of Surgical Oncology, Department of Surgery, University Maggiore Hospital della Carità, Novara, Italy.

Research Interests: surgical oncology of hepatobiliary and pancreatic diseases, surgical techniques, mininvasive approaches, surgical outcomes measures, hepatocellular carcinoma, cholangiocarcinoma, systemic treatments, translational research

Contributions:

Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma

Jean-François Dufour

Centre for Digestive Diseases, Lausanne, Switzerland.

Research Interests: MASLD, MASH, hepatocellular carcinoma

Hirayuki Enomoto

Division of Hepatobiliary and Pancreatic Diseases, Department of Gastroenterology, Hyogo Medical University, Nishinomiya, Hyogo, Japan.

Research Interests: hepatitis B virus, hepatitis C virus, liver cirrhosis, hepatocellular carcinoma

Isabel Fabregat

Bellvitge Biomedical Research Institute (IDIBELL), CIBEREHD and University of Barcelona, L’Hospitalet, Barcelona, Spain.

Research Interests: liver cancer, hepatocellular carcinoma, liver fibrosis, liver regeneration, TGF-beta, EGF, NADP hoxidases, NOX4, oxidative stress

Lynn G. Feun

Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA.

Research Interests: hepatocellular carcinoma, biomarkers, clinical trials, immunotherapy

Richard S. Finn

Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Research Interests: molecular therapies for hepatocellular carcinoma, systemic therapy, therapeutic strategies

Georgios Germanidis

First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Research Interests: HCC immunology, new ICI targets and strategies for neo/and or adjuvant HCC treatment, HCC microenvironment, new serum, plasma or biopsy and peripheral whole blood prognostic and predictive markers

Brian Kim Poh Goh

Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.

Research Interests: laparoscopic surgery, robotic surgery, liver resection, prognostication, hepatocellular carcinoma

Alessandro Granito

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Research Interests: autoimmune liver diseases, autoimmune hepatitis, autoimmune cirrhosis, hepatocellular carcinoma, cancer immunotherapy, cancer immunotherapy related adverse events

Contributions:

The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time

Xin-Yuan Guan

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Research Interests: stem cells, hepatocellular carcinoma, tumor microenvironment

Contributions:

Racial difference of mutational signature in hepatocellular carcinoma

Cancer stem cell-mediated therapeutic resistance in hepatocellular carcinoma

Ho-Seong Han

Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.

Research Interests: hepatobiliary-pancreatic surgery, hepatocellular carcinoma, pancreas cancer, biliary tract cancer

Contributions:

Minimally invasive surgery for gallbladder cancer at an expert center

Minimally invasive surgery for HCC

The role of minimally invasive surgery in the treatment of HCC

Minimally-invasive anatomical liver resection for hepatocellular carcinoma: a literature overview with technical and anatomical tips and tricks

Special Issue:

Minimally Invasive Surgery for HCC

Michael A. Heneghan

Institute of Liver Studies, King's College Hospital, Denmark Hill, London, UK.

Research Interests: autoimmune hepatitis, liver transplant, acute liver failure, primary biliary cholangitis

Jin-Lin Hou

Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Research Interests: clinical management of viral hepatitis, molecular virology, immunology of hepatitis B virus (HBV), severe acute respiratory syndrome (SARS) infection

Teh-Ia Huo

Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan;
Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan.

Research Interests: liver cancer, liver cirrhosis, viral hepatitis

Toru Ishikawa

Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.

Research Interests: hepatocellular carcinoma, portal hypertension, interventional radiology

Milind Javle

Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.

Research Interests: cholangiocarcinoma, biliary tract cancer

De-Ke Jiang

State Key Laboratory of Organ Failure Research, Guangdong Key Laboratory of Viral Hepatitis Research, Institutes of Liver Diseases Research of Guangdong Province, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Research Interests: genetic epidemiology, epigenetics, pharmacogenomics, molecular mechanism, chronic hepatitis B, hepatocellular carcinoma

Tatsuo Kanda

Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Japan;
Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.

Research Interests: liver cancer, immune related adverse events, HBV reactivation and viral hepatitis

Thomas Kietzmann

Faculty of Biochemistry and Molecular Medicine, University of Oulu, Biocenter Oulu, Oulu, Finland.

Research Interests: hypoxia, reactive oxygen species (ROS) Cancer, liver metabolism and zonation, cell signaling and transcriptional regulation, hemostasis and fibrinolysis, obesity and diabetes, insulin signaling, protein structure and stability

Jin-Wook Kim

Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Research Interests: viral hepatitis B and C, molecular biology, new drugs, clinical trials, liver fibrosis, liver cancer, pathogenesis, treatment

John S. Koskinas

Medical School National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

Research Interests: hepatocellular carcinoma, hepatitis B virus, hepatitis C virus, liver cirrhosis

Sandi A. Kwee

John A. Burns School of Medicine, University of Hawaii at Manoa, HI, USA.

Research Interests: molecular imaging, liquid biopsy, hepatocellular carcinoma biomarkers, immunotherapy, chronic liver disease

Edward Wolfgang Lee

Ronald Reagan UCLA Medical Center, Los Angeles, USA.

Research Interests: hepatocellular carcinoma, cholangiocarcinoma, interventional oncology, tumor ablation, radioembolization, portal hypertension, TIPS, RTO, liver lymphatics, biliary intervention

Ju-Seog Lee

Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Research Interests: genomics, biomarkers, HCC

Riccardo Lencioni

Cancer Imaging Program, Pisa University School of Medicine, Pisa, Italy.

Research Interests: imaging of liver tumors, loco-regional and systemic therapies for hepatocellular carcinoma, response evaluation criteria (RECIST and mRECIST)

Jan Lerut

Starzl Unit Abdominal Transplantation, University Hospitals Saint Luc, Université catholique Louvain, UCL Brussels, Brussels, Belgium.

Research Interests: transplantation oncology, immunosuppression and tolerance induction in liver transplantation, collaboration between East and Western surgical transplantation worlds

Nan Li

Department of Hepatic Surgery VI, AnTing District of the Eastern Hepatobiliary Surgery Hospital, Shanghai, China.

Research Interests: hepatocellular carcinoma, HBV-DNA, metastasis, transformation, liver transplantation

Amedeo Lonardo

Operating Unit of Metabolic Syndrome, Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy.

Research Interests: metabolic associated fatty liver disease, non-alcoholic fatty liver disease, endocrine disorders, sex differences in non-alcoholic fatty liver disease, metabolic syndrome, liver, hypobetalipoproteinemia, dysmetabolism in hepatitis C virus infection, diabetes in cirrhosis

Contributions:

Editorial: Metabolism and Target Organ Damage

Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?

Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies

The Fatty liver Index (FLI) 15 years later: a reappraisal

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Commentary: Of women, liver, and heart

Concise review: Breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease transmission and prevention

Is liver fibrosis a risk factor for gynecological cancers?

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?

Special Issue:

Organ Dysfunction in Metabolic-Associated Fatty Liver Disease: Effect of Cofactors

Liver Fibrosis in Metabolic Dysfunction: Cellular and Molecular Mechanisms, Innovative Diagnostics, and Emerging Therapeutic Approaches

Chun-Hong Ma

School of Basic Medical Science, Shandong University, Jinan, Shandong, China.

Research Interests: immune regulation, liver diseases, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, immunology

David C. Madoff

Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.

Research Interests: interventional radiology, liver cancer, thermal ablation, embolotherapy, liver regeneration

Special Issue:

Interventional Radiology in Treatment of Hepatocellular Carcinoma

Amit Mahipal

Department of Oncology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH, USA.

Research Interests: liver cancer, hepatocellular cancer, bile duct cancer, cholangiocarcinoma, systemic therapy, immunotherapy, chemotherapy, prognostic and predictive biomarkers, epidemiology

Fabio Marra

Dipartimento di Medicina Sperimentale Clinica, University of Florence, Florence, Italy.

Research Interests: cholangiocarcinoma, liver transplant, non-alcoholic steatohepatitis

Contributions:

Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components

Geoffrey Mccaughan

School of Medicine, University of Sydney, Sydney, Australia.

Research Interests: immunopathogenesis, chronic liver disease, liver autoimmunity, liver transplantation, hepatitis B and C virus, hepatocellular carcinoma

Contributions:

Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases

Manuela Merli

Department of Translational and Precision medicine, "Sapienza" University of Rome, Rome, Italy.

Research Interests: liver cirrhosis, portal hypertension, hepatic encephalopathy, bacteria infections in chronic liver disease, malnutrition and sarcopenia in liver disease, liver transplantation

Gabriele Missale

Unit of Infectious Diseases and Hepatology, University Hospital of Parma, Parma, Italy.

Research Interests: hepatocellular carcinoma, tumor immune microenvironment, hepatitis B virus, hepatitis C virus, immuneresponse, T cell, NK cell

Bruno Nardo

Department of Medical and Surgical Sciences (DIMEC), S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Research Interests: surgical oncology, hepatobiliary pancreatic surgery, liver transplantation, experimental surgery, liver regeneration

Kelvin K. Ng

Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.

Research Interests: liver cancer, liver transplantation

Contributions:

A combined endoscopic and robotic approach for Mirizzi syndrome: the short- and long-term outcomes

Matthias Ocker

Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Campus, Charité Mitte, Charité University Medicine Berlin, Berlin, Germany.

Research Interests: drug discovery and development, precision medicine for HCC and CCA, cell death pathways, early clinical trials, biomarkers

Peng Jin London Lucien Ooi

Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.

Research Interests: surgery and surgical oncology, hepato-pancreato-biliary, transplant surgery

Necati Örmeci

Department of Gastroenterology, Ankara University Medical School, Ankara, Turkey.

Research Interests: hepatitis B virus, hepatitis C virus, hepatitis D virus, hepatocellular carcinoma, hydatidCyst, portal hypertension

Valérie Paradis

Pathology Department, Hôpital Beaujon, AP-HP, Clichy, France.

Research Interests: liver tumors, tumor heterogeneity, molecular imaging, preneoplastic liver lesions

Young Nyun Park

Department of Pathology, Graduate School of Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.

Research Interests: hepatocellular carcinoma, liver diseases, liver cirrhosis, cholangiocarcinoma, liver failure

Rosa Maria Pascale

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Research Interests: hepatocarcinogenesis, model, genes alterations, signal transductions, targeting therapy

Contributions:

GNMT: a multifaceted suppressor of hepatocarcinogenesis

Tao Peng

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Research Interests: hepatocellular carcinoma, biomarkers, hepatitis B virus, liver surgery

Patrizia Pontisso

Department of Medicine, University of Padua, Padua, Italy.

Research Interests: liver cancer, cirrhosis, diagnostic markers, molecular biology of liver tumors, hepatocellular carcinoma, cholangiocarcinoma

Wenxin Qin

State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai, China.

Research Interests: molecular mechanism of hepatocarcinogenesis, novel strategies for diagnosis and treatment of hepatocellular carcinoma

Chun-Feng Qu

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Research Interests: hepatocellular carcinoma, HBsAg, hepatitis B virus, prevention

Matteo Ravaioli

General Surgery and Transplant Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Research Interests: liver and kidney transplantation, liver resection, hepato-pancreato-biliary surgery, ex-vivo perfusion and regenerative medicine, liver oncology

Contributions:

Neoadjuvant chemotherapy alone or combined with trans-arterial therapies for downstaging unresectable intrahepatic cholangiocarcinoma to surgical resection: a narrative review

Lorenza Rimassa

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Research Interests: hepatocellular carcinoma, biliary tract cancer, cholangiocarcinoma, liver cancer, new drugs, targeted agents, immunotherapy, biomarkers

Andrea Ruzzenente

Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, GB Rossi University Hospital, University of Verona, Verona, Italy.

Research Interests: minimally invasive liver surgery, robotic liver surgery, cholangiocarcinoma

Rodolfo Sacco

Gastroenterology and Digestive Endoscopy Unit, University of Foggia Medical School, Foggia, Italy.

Research Interests: hepatocellular carcinoma, immunotherapy, recurrence hepatocellular carcinoma, cholangiocarcinoma, liver cirrhosis, decompensated liver cirrhosis

Dalbir Singh Sandhu

Department of Gastroenterology and Hepatology, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH, USA.

Research Interests: liver cancer, biliary cancers, endoscopy

Fuat H. Saner

Department of General, Visceral and Transplantation Surgery, Essen University Medical Center, Essen, Germany.

Research Interests: liver cancer, acute and chronic liver failure, liver transplantation

Robert Schierwagen

Universitätsklinikum Münster, Munster, Germany.

Research Interests: advanced chronic liver diseases and the transition to malignancy, gut-liver axis, hepatocellular carcinoma, circulating biomarkers

Vishal Girishchandra Shelat

Tan Tock Seng Hospital, Singapore City, Singapore.

Research Interests: hepato-pancreatico-biliary surgery, liver resection, hepatocellular carcinoma, robotic hepatobiliary, pancreatic surgery

Dar-In Tai

Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.

Research Interests: hepatitis B virus, genetic polymorphism, hepatocellular carcinoma family, elastography, liver ultrasound

Rolf Teschke

Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Hanau, Germany.

Research Interests: clinical hepatology, DILI, HILI, RUCAM, drugs, herbs, alcohol, aliphatic halogenated hydrocarbons

Contributions:

Hepatocellular carcinoma in alcoholic liver disease: mechanistic considerations and clinical facts

Pierluigi Toniutto

Hepatology and Liver Transplant Unit, University of Udine, Udine, Italy.

Research Interests: liver cirrhosis, hepatocellular carcinoma, portal hypertension, viral hepatitis, liver transplantation

Contributions:

Risk factors for hepatocellular carcinoma recurrence after liver transplantation

Roberto Ivan Troisi

Division of HPB, Minimally Invasive and Robotic Surgery, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Research Interests: hepatocellular carcinoma, laparoscopic surgery, robotic surgery, robotic donor hepatectomy, liver transplantation, living donor liver transplant

Hong Tu

Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.

Research Interests: hepatitis B virus-related hepatocellular carcinoma carcinogenesis, hepatocellular carcinoma prediction, hepatocellular carcinoma prevention, tumor marker of hepatocellular carcinoma

Erica Villa

Division of Gastroenterology, University of Modena and Reggio Emilia, Modena, Italy.

Research Interests: hepatitis C virus, cirrhosis, direct-acting antiviral therapy, genotype, hepatitis B virus, platelets, portal hypertension, coagulation

Contributions:

Direct-acting antivirals and risk of hepatocellular carcinoma: from genetic signature to metabolic risk factors

Angiogenesis: the Yin and Yang in intrahepatic cholangiocarcinoma

Alessandro Vitale

Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padova, Second General Surgical Unit, Padova Teaching Hospital, Padua, Italy.

Research Interests: hepatocellular carcinoma, liver cancer, hepatobiliary surgery, liver transplantation, MASLD

Stephen J. Wigmore

Department of Clinical Surgery, University of Edinburgh and Edinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.

Research Interests: organ transplantation, liver, pancreas, biliary cancer surgery

Chun-Ming Wong

Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Research Interests: liver cancer genome and epigenome

Rong-Qian Wu

Research Institute of Advanced Surgical Technology and Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Research Interests: hepatocellular carcinoma, fatty liver disease, liver transplantation, ischemia reperfusion injury

Hong-Ping Xia

School of Basic Medical Sciences & State Key Laboratory of Reproductive Medicine & Key Laboratory of Antibody Technique of National Health Commission & Jiangsu Antibody Drug Engineering Research Center, Nanjing Medical University, Nanjing, Jiangsu, China.

Research Interests: viral and non-viral hepatocellular carcinoma, target therapy, molecular pathology, noncoding RNAs, immunotherapy

Yong-Bing Xiang

Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Research Interests: cancer statistics, cancer epidemiology, survival analysis, meta-analysis, cancer prevention

Contributions:

Global pattern and trend of liver cancer survival: a systematic review of population-based studies

Jin-Liang Xing

Tumor Markers Committee of China Anti-Cancer Association, Xi’an, Shaanxi, China.

Research Interests: hepatocellular carcinoma, molecular mechanism, circulating cell-free DNA, mtDNA, mitochondria, biomarkers

Fu Yang

Department of Medical Genetics, Second Military Medical University, Shanghai, China.

Research Interests: hepatocellular carcinoma, epigenetics, RNA post-transcriptional modification, tumor energy metabolism, tumor microenvironment, tumor immunity

Xin-Rong Yang

Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

Research Interests: diagnosis and surgical treatment of liver tumours, liver transplantation, clinical and translational research of hepatocellular carcinoma (HCC), liver cancer stem cell, circulating tumor cells

Dengfu Yao

Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.

Research Interests: early diagnosis and pathogenesis of hepatocellular carcinoma, hepatocarcinogenesis, biomarkers

Thomas Chung Cheung Yau

Department of Medicine, The University of Hong Kong, Hong Kong, China.

Research Interests: hepatobiliary carcinoma, early phase clinical trials, translational research

Jianhua Yin

Department of Epidemiology, Second Military Medical University, Shanghai, China.

Research Interests: hepatitis B virus, hepatocellular carcinoma, evolution, prediction, prophylaxis, therapeutic option, biomarker

Contributions:

Association of human leukocyte antigen-DR-DQ-DP haplotypes with the risk of hepatitis B virus-related hepatocellular carcinoma

Xue-Hong Zhang

Department of Nutrition, Harvard TH Chan School of Public Health, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Research Interests: liver cancer epidemiology, early detection, cancer survivorship, nutritional epidemiology, liver disease, liver cirrhosis, biomarkers, molecular epidemiology

Founding Editor-in-Chief

Joseph F. Buell

Department of Surgery, Mission Health, HCA North Carolina Division, University of North Carolina, Asheville, NC, USA.

All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/